Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspin trial of perioperative aspirin continuation versus discontinuation in elective spinal surgery
NL-OMON54741Recruiting
- Sponsor
- Haaglanden Medical Centre
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in cardiac morbidity and cerebrovascular disease (2 arms), sponsored by Haaglanden Medical Centre. Primary endpoints: Perioperative blood loss, Hemorrhage-related complications and 6 more. Started Jan 2022; status: recruiting.
02
Drugs
aspirin
03
Conditions
cardiac morbiditycerebrovascular disease
Beyond the preview
Go deeper on NL-OMON54741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54741.